Treatment of sentinel node-positive breast cancer

References

• Neville AM, Price KN, Gelber RD, Goldhirsch A. Axillary node micrometastases and breast cancer. Lancet337, 1110 (1991).
   PubMed Web of Science ®Google Scholar
• Cote RJ, Peterson HF, Chaiwun B et al. Role of immunohistochemical detection of lymph-node metastases in management of breast cancer. International Breast Cancer Study Group. Lancet354, 896–900 (1999).
   PubMed Web of Science ®Google Scholar
• Cserni G, Amendoeira I, Apostolikas N et al. Discrepancies in current practice of pathological evaluation of sentinel lymph nodes in breast cancer. Results of a questionnaire based survey by the European Working Group for Breast Screening Pathology. J. Clin. Pathol.57, 695–701 (2004).
   PubMed Web of Science ®Google Scholar
• White RL Jr, Wilke LG. Update on the NSABP and ACOSOG breast cancer sentinel node trials. Am. Surg.70, 420–424 (2004).
   PubMed Web of Science ®Google Scholar
• Singletary SE, Allred C, Ashley P et al. Revision of the American Joint Committee on Cancer staging system for breast cancer. J. Clin. Oncol.20, 3628–3636 (2002).
   PubMed Web of Science ®Google Scholar
• Cserni G, Gregori D, Merletti F et al. Meta-analysis of non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer. Br. J. Surg.91, 1245–1252 (2004).
   PubMed Web of Science ®Google Scholar
• Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation. N. Engl. J. Med.347, 567–575 (2002).
   PubMed Web of Science ®Google Scholar
• Carlson RW, Brown E, Burstein HJ et al. NCCN Task Force Report: adjuvant therapy for breast cancer. J. Natl Compr. Canc. Netw.4(Suppl. 1), S1–S26 (2006).
   PubMedGoogle Scholar
• Recht A, Edge SB, Solin LJ et al. Postmastectomy radiotherapy: clinical practice guidelines of the American Society of Clinical Oncology. J. Clin. Oncol.19, 1539–1569 (2001).
   PubMed Web of Science ®Google Scholar
• Harris JR, Halpin-Murphy P, McNeese M, Mendenhall NP, Morrow M, Robert NJ. Consensus statement on postmastectomy radiation therapy. Int. J. Radiat. Oncol. Biol. Phys.44, 989–990 (1999).
   PubMed Web of Science ®Google Scholar
• Barranger E, Dubernard G, Fleurence J, Antoine M, Darai E, Uzan S. Subjective morbidity and quality of life after sentinel node biopsy and axillary lymph node dissection for breast cancer. J. Surg. Oncol.92, 17–22 (2005).
   PubMed Web of Science ®Google Scholar
• Peintinger F, Reitsamer R, Stranzl H, Ralph G. Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients. Br. J. Cancer89, 648–652 (2003).
   PubMed Web of Science ®Google Scholar
• Van Zee KJ, Manasseh DM, Bevilacqua JL et al. A nomogram for predicting the likelihood of additional nodal metastases in breast cancer patients with a positive sentinel node biopsy. Ann Surg. Oncol.10, 1140–1151 (2003).
   PubMed Web of Science ®Google Scholar
• Lambert LA, Ayers GD, Hwang RF et al. Validation of a breast cancer nomogram for predicting nonsentinel lymph node metastases after a positive sentinel node biopsy. Ann. Surg. Oncol.13, 310–320 (2006).
   PubMed Web of Science ®Google Scholar
• Smidt ML, Kuster DM, van der Wilt GJ, Thunnissen FB, Van Zee KJ, Strobbe LJ. Can the Memorial Sloan-Kettering Cancer Center nomogram predict the likelihood of nonsentinel lymph node metastases in breast cancer patients in The Netherlands? Ann. Surg. Oncol.12, 1066–1072 (2005).
   PubMed Web of Science ®Google Scholar
• Degnim AC, Reynolds C, Pantvaidya G et al. Nonsentinel node metastasis in breast cancer patients: assessment of an existing and a new predictive nomogram. Am. J. Surg.190, 543–550 (2005).
   PubMed Web of Science ®Google Scholar
• Kocsis L, Svebis M, Boross G et al. Use and limitations of a nomogram predicting the likelihood of non-sentinel node involvement after a positive sentinel node biopsy in breast cancer patients. Am. Surg.70, 1019–1024 (2004).
   PubMed Web of Science ®Google Scholar
• Soni NK, Carmalt HL, Gillett DJ, Spillane AJ. Evaluation of a breast cancer nomogram for prediction of nonsentinel lymph node positivity. Eur. J. Surg. Oncol.31, 958–964 (2005).
   PubMed Web of Science ®Google Scholar
• Specht MC, Kattan MW, Gonen M, Fey J, Van Zee KJ. Predicting nonsentinel node status after positive sentinel lymph biopsy for breast cancer: clinicians versus nomogram. Ann. Surg. Oncol.12, 654–659 (2005).
   PubMed Web of Science ®Google Scholar
• Barranger E, Coutant C, Flahault A, Delpech Y, Darai E, Uzan S. An axilla scoring system to predict non-sentinel lymph node status in breast cancer patients with sentinel lymph node involvement. Breast Cancer Res. Treat.91, 113–119 (2005).
   PubMed Web of Science ®Google Scholar
• Chagpar A, Scoggins CR, Martin RC et al. Prediction of sentinel lymph node-only disease in women with invasive breast cancer. Am. J. Surg. (2006) (In Press).
   Google Scholar
• Leidenius MH, Vironen JH, Riihela MS et al. The prevalence of non-sentinel node metastases in breast cancer patients with sentinel node micrometastases. Eur. J. Surg. Oncol.31, 13–18 (2005).
   PubMed Web of Science ®Google Scholar
• Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P. Axillary lymph node dissection for T1a breast carcinoma. Is it indicated? Cancer73, 664–667 (1994).
   PubMed Web of Science ®Google Scholar
• Mignotte H, Treilleux I, Faure C, Nessah K, Bremond A. Axillary lymph-node dissection for positive sentinel nodes in breast cancer patients. Eur. J. Surg. Oncol.28, 623–626 (2002).
   PubMed Web of Science ®Google Scholar
• Travagli JP, Atallah D, Mathieu MC et al. Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis. Eur. J. Surg. Oncol.29, 403–406 (2003).
   PubMed Web of Science ®Google Scholar
• Katz A, Niemierko A, Gage I et al. Factors associated with involvement of four or more axillary nodes for sentinel lymph node-positive patients. Int. J. Radiat. Oncol. Biol. Phys.65, 40–44 (2006).
   PubMed Web of Science ®Google Scholar
• Shahar KH, Hunt KK, Thames HD et al. Factors predictive of having four or more positive axillary lymph nodes in patients with positive sentinel lymph nodes: implications for selection of radiation fields. Int. J. Radiat. Oncol. Biol. Phys.59, 1074–1079 (2004).
   PubMed Web of Science ®Google Scholar
• Rivers AK, Griffith KA, Hunt KK et al. Clinicopathologic features associated with having four or more metastatic axillary nodes in breast cancer patients with a positive sentinel lymph node. Ann. Surg. Oncol.13, 36–44 (2006).
   PubMed Web of Science ®Google Scholar
• Chagpar A, Scoggins CR, Martin RC et al. Predicting patients at low probability of requiring post-mastectomy radiation therapy. Ann. Surg. Oncol. (2006) (In Press).
   Google Scholar
• Mullenix PS, Brown TA, Meyers MO et al. The association of cytokeratin-only-positive sentinel lymph nodes and subsequent metastases in breast cancer. Am. J. Surg.189, 606–609 (2005).
   PubMed Web of Science ®Google Scholar
• Inokuchi M, Ninomiya I, Tsugawa K, Terada I, Miwa K. Quantitative evaluation of metastases in axillary lymph nodes of breast cancer. Br. J. Cancer89, 1750–1756 (2003).
   PubMed Web of Science ®Google Scholar
• Wong SL, Chao C, Edwards MJ, Simpson D, McMasters KM. The use of cytokeratin staining in sentinel lymph node biopsy for breast cancer. Am. J. Surg.182, 330–334 (2001).
   PubMed Web of Science ®Google Scholar
• Pendas S, Dauway E, Cox CE et al. Sentinel node biopsy and cytokeratin staining for the accurate staging of 478 breast cancer patients. Am. Surg.65, 500–505 (1999).
   PubMed Web of Science ®Google Scholar
• Schreiber RH, Pendas S, Ku NN et al. Microstaging of breast cancer patients using cytokeratin staining of the sentinel lymph node. Ann. Surg. Oncol.6, 95–101 (1999).
   PubMed Web of Science ®Google Scholar
• McIntosh SA, Going JJ, Soukop M, Purushotham AD, Cooke TG. Therapeutic implications of the sentinel lymph node in breast cancer. Lancet354, 570 (1999).
   PubMed Web of Science ®Google Scholar
• Pargaonkar AS, Beissner RS, Snyder S, Speights VO Jr. Evaluation of immunohistochemistry and multiple-level sectioning in sentinel lymph nodes from patients with breast cancer. Arch. Pathol. Lab. Med.127, 701–705 (2003).
   PubMed Web of Science ®Google Scholar
• Stitzenberg KB, Calvo BF, Iacocca MV et al. Cytokeratin immunohistochemical validation of the sentinel node hypothesis in patients with breast cancer. Am. J. Clin. Pathol.117, 729–737 (2002).
   PubMed Web of Science ®Google Scholar
• Weaver DL, Krag DN, Ashikaga T, Harlow SP, O’Connell M. Pathologic analysis of sentinel and nonsentinel lymph nodes in breast carcinoma: a multicenter study. Cancer88, 1099–1107 (2000).
   PubMed Web of Science ®Google Scholar
• Gillanders WE, Mikhitarian K, Hebert R et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlates with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann. Surg.239, 828–837 (2004).
   PubMed Web of Science ®Google Scholar
• Sakaguchi M, Virmani A, Dudak MW et al. Clinical relevance of reverse transcriptase-polymerase chain reaction for the detection of axillary lymph node metastases in breast cancer. Ann. Surg. Oncol.10, 117–125 (2003).
   PubMed Web of Science ®Google Scholar
• Manzotti M, Dell’Orto P, Maisonneuve P, Zurrida S, Mazzarol G, Viale G. Reverse transcription-polymerase chain reaction assay for multiple mRNA markers in the detection of breast cancer metastases in sentinel lymph nodes. Int. J. Cancer95, 307–312 (2001).
   PubMed Web of Science ®Google Scholar
• Cserni G, Burzykowski T, Vinh-Hung V et al. Axillary sentinel node and tumour-related factors associated with non-sentinel node involvement in breast cancer. Jpn. J. Clin. Oncol.34, 519–524 (2004).
   PubMed Web of Science ®Google Scholar
• Calhoun KE, Hansen NM, Turner RR, Giuliano AE. Nonsentinel node metastases in breast cancer patients with isolated tumor cells in the sentinel node: implications for completion axillary node dissection. Am. J. Surg.190, 588–591 (2005).
   PubMed Web of Science ®Google Scholar
• Schrenk P, Konstantiniuk P, Wolfl S et al. Prediction of non-sentinel lymph node status in breast cancer with a micrometastatic sentinel node. Br. J. Surg.92, 707–713 (2005).
   PubMed Web of Science ®Google Scholar
• Fournier K, Schiller A, Perry RR, Laronga C. Micrometastasis in the sentinel lymph node of breast cancer does not mandate completion axillary dissection. Ann. Surg.239, 859–863 (2004).
   PubMed Web of Science ®Google Scholar
• Nos C, Harding-MacKean C, Freneaux P et al. Prediction of tumour involvement in remaining axillary lymph nodes when the sentinel node in a woman with breast cancer contains metastases. Br. J. Surg.90, 1354–1360 (2003).
   PubMed Web of Science ®Google Scholar
• Yu JC, Hsu GC, Hsieh CB, Sheu LF, Chao TY. Prediction of metastasis to non-sentinel nodes by sentinel node status and primary tumor characteristics in primary breast cancer in Taiwan. World J. Surg.29, 813–818 (2005).
   PubMed Web of Science ®Google Scholar
• van IV, Leidenius M, Krogerus L, von Smitten K. Predictive factors for the status of non-sentinel nodes in breast cancer patients with tumor positive sentinel nodes. Breast Cancer Res.Treat.82, 39–45 (2003).
   PubMed Web of Science ®Google Scholar
• Hung WK, Chan MC, Mak KL et al. Non-sentinel lymph node metastases in breast cancer patients with metastatic sentinel nodes. ANZ J. Surg.75, 27–31 (2005).
   PubMed Web of Science ®Google Scholar
• Fleming FJ, Kavanagh D, Crotty TB et al. Factors affecting metastases to non-sentinel lymph nodes in breast cancer. J. Clin. Pathol.57, 73–76 (2004).
   PubMed Web of Science ®Google Scholar
• den Bakker MA, van Weeszenberg A, de Kanter AY et al. Non-sentinel lymph node involvement in patients with breast cancer and sentinel node micrometastasis; too early to abandon axillary clearance. J. Clin. Pathol.55, 932–935 (2002).
   PubMed Web of Science ®Google Scholar
• Reynolds C, Mick R, Donohue JH et al. Sentinel lymph node biopsy with metastasis: can axillary dissection be avoided in some patients with breast cancer? J. Clin. Oncol.17, 1720–1726 (1999).
   PubMed Web of Science ®Google Scholar
• Veronesi U, Paganelli G, Viale G et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N. Engl. J. Med.349, 546–553 (2003).
   PubMed Web of Science ®Google Scholar
• Schijven MP, Vingerhoets AJ, Rutten HJ et al. Comparison of morbidity between axillary lymph node dissection and sentinel node biopsy. Eur. J. Surg. Oncol.29, 341–350 (2003).
   PubMed Web of Science ®Google Scholar
• Haid A, Koberle-Wuhrer R, Knauer M et al. Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res. Treat.73, 31–36 (2002).
   PubMed Web of Science ®Google Scholar
• Blanchard DK, Donohue JH, Reynolds C, Grant CS. Relapse and morbidity in patients undergoing sentinel lymph node biopsy alone or with axillary dissection for breast cancer. Arch. Surg.138, 482–487 (2003).
   PubMedGoogle Scholar
• Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC. Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am. J. Surg.183, 23–27 (2002).
   PubMed Web of Science ®Google Scholar
• Golshan M, Martin WJ, Dowlatshahi K. Sentinel lymph node biopsy lowers the rate of lymphedema when compared with standard axillary lymph node dissection. Am. Surg.69, 209–211 (2003).
   PubMed Web of Science ®Google Scholar
• Mansel RE, Fallowfield L, Kissin M et al. Randomized multicenter trial of sentinel node biopsy versus standard axillary treatment in operable breast cancer: the ALMANAC trial. J. Natl Cancer Inst.98, 599–609 (2006).
   PubMed Web of Science ®Google Scholar